2026³â 06¿ù 19ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Merz Aesthetics Unveils Ultherapy PRIME FDA-Cleared for Arms, Abdomen With Real-Time Ultrasound Visualization

Latest FDA Clearance Expands to Improve the Appearance of Skin Laxity on the Anterior Arms, Posterior Arms and Abdomen, to launch in the United States before worldwide expansion.
´º½ºÀÏÀÚ: 2025-12-10

RALEIGH, N.C. -- Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced the U.S. Food and Drug Administration (FDA) clearance of Ultherapy PRIME to improve the appearance of skin laxity on the anterior arms, posterior arms and abdomen.

Ultherapy PRIME is the only FDA-cleared solution with real-time visualization to treat the face**, neck, décolleté and now body*.[1] The new indications will launch in the U.S. before expanding to markets worldwide.

“This FDA clearance is proof of our incredible momentum, following last year’s successful Ultherapy PRIME launch,” said Bob Rhatigan, CEO, Merz Aesthetics. “By extending our reach from face** to body*, we’re unlocking new treatment possibilities, meeting rising patient demand, and reinforcing our leadership in non-invasive skin lifting and firming.”

Ultherapy PRIME builds on the legacy of Ultherapy®, which is recognized as the Gold Standard in non-invasive skin lifting with over 3.5 million treatments performed globally and a 95% satisfaction rate.[1-3] The skin lifting market is expanding rapidly and is expected to grow approximately 9% by 2030, driven largely by life stage (post-partum, menopause), and weight loss related skin laxity patient demographics.[4]

Ultherapy PRIME stimulates the body’s natural collagen and elastin production precisely where it’s needed. In just one session, Ultherapy PRIME lifts the brows, the skin under the chin and on the neck, and smooths lines and wrinkles on the décolleté. Now, Ultherapy PRIME also firms and tones the skin on the arms and abdomen - with no downtime and safe for all skin types. [1,5] It offers personalized, visible natural-looking results, along with younger looking skin, that can last up to a year or more on the face** and 6 months or more on the arms and abdomen.[4-7]

“The Ultherapy PRIME platform offers all the signature benefits of Ultherapy for non-invasive skin lifting, plus the ability to improve the quality of skin on the abdomen and arms in a single session,” said Sabrina Fabi, MD, world-renowned, Double Board-Certified Dermatologist and Dermatological Cosmetic Surgeon from San Diego, California. “This is of great value for my patients who want to keep the skin on their body looking as youthful as the skin on their face.”[6,8,9]

“These new indications for arms and abdomen* strengthen Ultherapy PRIME’s position as a multi-purpose skin lifting, smoothing and firming treatment solution,” said Alexis Stern, Chief Marketing Officer, Merz Aesthetics. “This exciting journey started a year ago when we launched Ultherapy PRIME as a platform to lift the face**, and with this next phase of growth we are able to firm and tone the body*.”[1,8]

References:

[1] Ulthera® Instructions for Use.
[2] Werschler WP, Werschler PS. Long-term efficacy of micro-focused ultrasound with visualization for lifting and tightening lax facial and neck skin using a customized vectoring treatment method. J Clin Aesthet Dermatol. 2016;9(2):27-33.
[3] Ultherapy PRIME Letter of Treatments Sold. Merz Aesthetics®, Herring L, Sr Director, Regulatory Affairs, Advertising and Promotion. July 16, 2025. Data on File.
[4] Data on File. Merz Custom Market Forecasting 2025.
[5] Marquardt K, Hartmann C, Wegener F, et al. Microfocused ultrasound with visualization induces remodeling of collagen and elastin within the skin. J Cosmet Dermatol. 2025;24(1):e16638. doi:10.1111/jocd.16638.
[6] Fabi SG, Joseph J, Sevi J, Green JB, Peterson JD. Optimizing patient outcomes by customizing treatment with microfocused ultrasound with visualization: gold standard consensus guidelines from an expert panel. J Drugs Dermatol. 2019;18(5):426-432.
[7] Park JY, et al. Customized Treatment Using Microfocused Ultrasound with Visualization for Optimized Patient Outcomes: A Review of Skin tightening Energy Technologies and a Pan-Asian Adaptation of the Expert Panel’s Gold Standard Consensus. J Clin Aesthet Dermatol. 2021;14(5): E70-E79.
[8] Sasaki G, Grossman J, Fabi SG, et al. Stimulation of Collagen Synthesis in Human Skin Following Microfocused Ultrasound Therapy. Presented at the ASDS 2018 Annual Meeting.
[9] Goldie K, Kerscher M, Fabi SG, Hirano C, Landau M, Lim TS, Woolery-Lloyd H, Mariwalla K, Park JY, Yutskovskaya Y. Skin Quality - A Holistic 360° View: Consensus Results. Clin Cosmet Investig Dermatol. 2021 Jun 14;14:643-654. doi: 10.2147/CCID.S309374. PMID: 34163203; PMCID: PMC8214518.



 Àüü´º½º¸ñ·ÏÀ¸·Î

SLB Industrializes AI for the Energy Industry with NVIDIA
Gradiant Delivers HyperSolved, Its AI Data Center Solution, to Leading Global Hyperscalers
NetApp, Red Hat Partner to Advance Data Protection and Scale for OpenShift Deployments
Cognite Flows¢â: Fully Integrated AI-Native Industrial Experience Driving Customer Value
Datang Mobile, KPN, NEC and Wilus Join Sisvel POS Patent Pool as Incentive Deadline Approaches
Thales Launches Imperva for Google Cloud, Delivering Enterprise-Grade App Security Directly on Google Cloud
Murata Partners with Synopsys to Deliver Simulation Models via Ansys Electromagnetic and Thermal Tools

 

iQmetrix Joins TM Forum as ODA Partner, Offering Telecoms a Faster Pat...
OPAQUE Acquires Abu Dhabi AI Tech from TII, Extending Confidential AI ...
Lenovo Enables One-Week Deployment of Production-Ready Agentic AI to T...
Oral-B Unveils The Big Rethink 2026, Launching Europe¡¯s Largest Disab...
BeOne Medicines¡¯ BEQALZI (sonrotoclax) Wins FDA Approval as First BCL...
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Adva...
LG Electronics Launches 2026 Micro and Mini RGB evo, Advancing High-Pu...

 


°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..